NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

惡性貧血診斷和治療市場:2021-2027

Pernicious Anemia Diagnosis and Treatment Market 2021-2027

出版商 Orion Market Research Pvt Ltd 商品編碼 1025326
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
惡性貧血診斷和治療市場:2021-2027 Pernicious Anemia Diagnosis and Treatment Market 2021-2027
出版日期: 2021年06月22日內容資訊: 英文
簡介

在預測期內,惡性貧血診斷和治療的市場規模預計將以 7.1% 的顯著複合年增長率增長。然而,惡性貧血治療劑的高價是市場的主要障礙。出於這個原因,許多人對這種疾病置之不理。然而,政府意識的提高將為市場帶來積極的變化。

患有惡性貧血的患者可能會因感染 COVID-19 而死亡。這是由於缺乏維生素 B-12 引起的細胞因子風暴。在這種情況下,患者的免疫系統開始作用於他的身體,損害多個器官。即使在 COVID-19 痊癒後,這種器官損傷也會導致患者死亡。因此,它已成為世界各國政府和醫療機構的主要關注點。

本報告探討了惡性貧血診斷和治療市場,提供了市場概況、診斷、治療和地區趨勢,以及進入市場的公司概況。

目錄

第 1 章報告概述

第 2 章市場概覽和洞察

  • 調查範圍
  • 分析師洞察和當前市場趨勢

第三章競爭形勢

  • 主要公司分析
    • 概述
    • 財務分析
    • SWOT 分析
    • 近期趨勢
  • 重要的戰略分析
  • COVID-19 對主要參與者的影響

第 4 章市場決定因素

  • 增長因素
  • 抑製器
  • 市場機會

第五章市場細分

  • 全球惡性貧血診斷和治療市場,按診斷分類
    • 全血細胞計數測試
    • 維生素 B-12 缺乏測試
    • 活檢
    • 內在因子缺乏測試
  • 按治療分類的全球惡性貧血診斷和治療市場
    • 維生素 B-12 注射液
    • 維生素B-12丸
    • 其他(噴霧)

第六章區域分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 意大利
    • 西班牙
    • 法國
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他
  • 其他領域

第 7 章公司簡介

  • American Regent, Inc.
  • Bio-Rad Laboratories, Inc.
  • BioVision, Inc.
  • Cleveland HeartLab, Inc.
  • Daiichi Sankyo Co., Ltd.
  • DSM Nutritional Products AG
  • Emisphere Technologies, Inc.
  • Endo Pharmaceuticals Plc.
  • GlaxoSmithKline Plc.
  • Guardian Healthcare Services Pvt. Ltd.
  • Laboratory Corporation of America Holdings
  • Monobind, Inc.
  • Pfizer, Inc.
  • Pharmacosmos A/S
  • Pharmavite, LLC
  • Premier Research Labs
  • Swanson Health Products
  • The Synergy Company
  • Trinity Biotech Plc.
目錄
Product Code: OMR2023738

Global Pernicious Anemia Diagnosis and Treatment Market Size, Share & Trends Analysis Report by Diagnosis (Complete Blood Count Test, Vitamin B-12 Deficiency Test, Biopsy, and Intrinsic Factor Deficiency Test), By Treatment (Vitamin B-12 Injections, Vitamin B-12 Pills and Other), Forecast Period 2021-2027

The pernicious anemia diagnosis and treatment market is anticipated to grow at a substantial CAGR of 7.1% during the forecast period. The high cost of medical drugs for the treatment of pernicious anemia is the major restraining factor for the market. Due to this reason lots of people neglect the prevalence of this disease. However, the increasing government's effort for generating awareness will bring a positive change in the market.

Patients with pernicious anemia are susceptible to mortality after the COVID-19 infection. This is due to the cytokine storm due to the deficiency of vitamin B-12. Under this situation, the patient's immune system starts working against their body and damages multiple organs. This failure of organs causes the death of patients even after the curing of COVID-19. Due to this reason, it is a matter of great concern for the global governments and health fraternities.

The global pernicious anemia diagnosis and treatment market is segmented based on diagnosis, and treatment. Based on the material, the market is segmented into complete blood count tests, vitamin B-12 deficiency tests, biopsy, and intrinsic factor deficiency tests. Based on the treatment, the market is segmented into vitamin B-12 injections and vitamin B-12 pills. Apart from this, by symptoms, the market is segmented into weight loss, shortness of breath, diarrhea, fatigue, and weakness, and others.

Geographically, the market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. The people of Northern Europe and Africa are more descent to the pernicious anemia. Additionally, it is more prone to elderly people as their stomach capacity is weak to absorb vitamin B-12. The increasing investment of the European government is expected to give considerable growth to the pernicious anemia market in the region.

The competition in the global pernicious anemia diagnosis and treatment market is moderate as the companies present in the market are not so active. The market players are engaged in providing various B-12 vitamin injections, sprays, immunosuppressant drugs, and tests for Intrinsic factor deficiency. The key players in the pernicious anemia market includes American Regent, Inc., Daiichi Sankyo Co, Ltd., Emisphere Technologies, Inc, and so on. The companies are engaged in rapid research and development for the development of effective treatment measures for the disease.

Research Methodology

The market study of the global pernicious anemia diagnosis and treatment market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

Financial reports of companies involved in the market.

Whitepapers, research papers, and news blogs.

Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

Global Pernicious Anemia Diagnosis and Treatment Market Research and Analysis by Diagnosis

Global Pernicious Anemia Diagnosis and Treatment Market Research and Analysis by Treatment

The Report Covers

Comprehensive research methodology of the global pernicious anemia diagnosis and treatment market.

This report also includes a detailed and extensive market overview with key analyst insights.

An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.

Analysis of regional regulations and other government policies impacting the global pernicious anemia diagnosis and treatment market.

Insights about market determinants that are stimulating the global pernicious anemia diagnosis and treatment market.

Detailed and extensive market segments with the regional distribution of forecasted revenues.

Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • Impact of COVID-19 on the Global Pernicious Anemia Diagnosis and Treatment Market
  • Recovery Scenario of Global Pernicious Anemia Diagnosis and Treatment Market
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. BY Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
    • 3.1.1. Overview
    • 3.1.2. Financial Analysis
    • 3.1.3. SWOT Analysis
    • 3.1.4. Recent Developments
  • 3.2. Key Strategy Analysis
  • 3.3. Impact of COVID-19 on Key Players

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Pernicious Anemia Diagnosis and Treatment Market by Diagnosis
    • 5.1.1. Complete Blood Count Test
    • 5.1.2. Vitamin B-12 Deficiency Test
    • 5.1.3. Biopsy
    • 5.1.4. Intrinsic Factor Deficiency Test
  • 5.2. Global Pernicious Anemia Diagnosis and Treatment Market by Treatment
    • 5.2.1. Vitamin B-12 Injections
    • 5.2.2. Vitamin B-12 Pills
    • 5.2.3. Other (Spray)

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. South Korea
    • 6.3.5. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. American Regent, Inc.
  • 7.2. Bio-Rad Laboratories, Inc.
  • 7.3. BioVision, Inc.
  • 7.4. Cleveland HeartLab, Inc.
  • 7.5. Daiichi Sankyo Co., Ltd.
  • 7.6. DSM Nutritional Products AG
  • 7.7. Emisphere Technologies, Inc.
  • 7.8. Endo Pharmaceuticals Plc.
  • 7.9. GlaxoSmithKline Plc.
  • 7.10. Guardian Healthcare Services Pvt. Ltd.
  • 7.11. Laboratory Corporation of America Holdings
  • 7.12. Monobind, Inc.
  • 7.13. Pfizer, Inc.
  • 7.14. Pharmacosmos A/S
  • 7.15. Pharmavite, LLC
  • 7.16. Premier Research Labs
  • 7.17. Swanson Health Products
  • 7.18. The Synergy Company
  • 7.19. Trinity Biotech Plc.

LIST OF TABLES

  • 1. GLOBAL PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2020-2027 ($ MILLION)
  • 2. GLOBAL COMPLETE BLOOD COUNT TEST MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 3. GLOBAL VITAMIN B-12 DEFICIENCY TEST MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 4. GLOBAL BIOPSY MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 5. GLOBAL INTRINSIC FACTOR DEFICIENCY TEST MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 6. GLOBAL PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2020-2027 ($ MILLION)
  • 7. GLOBAL VITAMIN B-12 INJECTIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 8. GLOBAL VITAMIN B-12 PILLS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 9. GLOBAL OTHER TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 10. GLOBAL PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2020-2027 ($ MILLION)
  • 11. NORTH AMERICAN PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 12. NORTH AMERICAN PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2020-2027 ($ MILLION)
  • 13. NORTH AMERICAN PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2020-2027 ($ MILLION)
  • 14. EUROPEAN PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 15. EUROPEAN PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2020-2027 ($ MILLION)
  • 16. EUROPEAN PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2020-2027 ($ MILLION)
  • 17. ASIA-PACIFIC PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 18. ASIA-PACIFIC PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2020-2027 ($ MILLION)
  • 19. ASIA-PACIFIC PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2020-2027 ($ MILLION)
  • 20. REST OF THE WORLD PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2020-2027 ($ MILLION)
  • 21. REST OF THE WORLD PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2020-2027 ($ MILLION)

LIST OF FIGURES

  • 1. IMPACT OF COVID-19 ON GLOBAL PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET, 2020-2027 ($ MILLION)
  • 2. IMPACT OF COVID-19 ON GLOBAL PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET BY SEGMENT, 2020-2027 ($ MILLION)
  • 3. RECOVERY OF GLOBAL PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET, 2021-2027 (%)
  • 4. GLOBAL PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET SHARE BY DIAGNOSIS, 2020 VS 2027 (%)
  • 5. GLOBAL COMPLETE BLOOD COUNT TEST MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 6. GLOBAL VITAMIN B-12 DEFICIENCY TEST MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 7. GLOBAL BIOPSY MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 8. GLOBAL INTRINSIC FACTOR DEFICIENCY TEST MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 9. GLOBAL PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET SHARE BY TREATMENT, 2020 VS 2027 (%)
  • 10. GLOBAL VITAMIN B-12 INJECTIONSMARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 11. GLOBAL VITAMIN-B12 PILLSMARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 12. GLOBAL PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 13. NORTH AMERICAN PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 14. UNITED STATES PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 15. CANADA PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 16. EUROPEAN PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 17. UK PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 18. GERMANY PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 19. SPAIN PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 20. FRANCE PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 21. ITALY PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 22. ROE PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 23. ASIA-PACIFIC PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 24. INDIA PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 25. CHINA PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 26. JAPAN PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 27. SOUTH KOREA PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 28. REST OF ASIA-PACIFIC PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 29. REST OF THE WORLD PERNICIOUS ANEMIA DIAGNOSIS AND TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)